Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates

Compugen (CGEN) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1,053.85%. A quarter ago, it was expected that this drug developer would post a loss of $0.09 per share when it actually produced a loss of $0.07, delivering a surprise of +22.22%.Over the last four quarters, the company ha ...